HEALTHY EXTRACTS INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HEALTHY EXTRACTS INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.51M | Apr 9, 2026 |
| FY2025 | Dec 31, 2024 | $3.11M | Apr 9, 2026 |
| FY2024 | Dec 31, 2023 | $2.49M | Apr 22, 2025 |
| FY2023 | Dec 31, 2022 | $2.25M | Apr 1, 2024 |
| FY2021 | Dec 31, 2021 | $766.4K | Apr 1, 2022 |
| FY2020 | Dec 31, 2020 | $135.9K | Aug 3, 2021 |
| FY2020 | Dec 31, 2019 | $176.8K | Aug 3, 2021 |
| FY2019 | Dec 31, 2018 | $67.1K | Aug 10, 2020 |
| FY2018 | Dec 31, 2017 | $7.6K | Apr 1, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $128.1K | Jun 8, 2018 |
| FY2017 | Dec 31, 2016 | $162.8K | Jun 8, 2018 |
| FY2016 | Dec 31, 2015 | $115.6K | Apr 17, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.42M | Apr 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.91M | Apr 9, 2026 |
| FY2024 | Dec 31, 2023 | $1.62M | Apr 22, 2025 |
| FY2023 | Dec 31, 2022 | $1.37M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $695.1K | Mar 31, 2023 |
| FY2020 | Dec 31, 2020 | ($1.28M) | Aug 3, 2021 |
| FY2020 | Dec 31, 2019 | ($253.9K) | Aug 3, 2021 |
| FY2019 | Dec 31, 2018 | $38.5K | Aug 10, 2020 |
| FY2018 | Dec 31, 2017 | $2.8K | Apr 1, 2020 |
| FY2017 | Dec 31, 2016 | $135.8K | Jun 8, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($881.1K) | Apr 9, 2026 |
| FY2025 | Dec 31, 2024 | ($840.7K) | Apr 9, 2026 |
| FY2024 | Dec 31, 2023 | ($2.47M) | Apr 22, 2025 |
| FY2023 | Dec 31, 2022 | ($983.1K) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($1.99M) | Mar 31, 2023 |
| FY2020 | Dec 31, 2020 | ($1.63M) | Aug 3, 2021 |
| FY2020 | Dec 31, 2019 | ($37.9K) | Aug 3, 2021 |
| FY2019 | Dec 31, 2018 | ($3.33M) | Aug 10, 2020 |
| FY2018 | Dec 31, 2017 | ($3.56M) | Apr 1, 2020 |
| FY2017 | Dec 31, 2016 | ($3.37M) | Jun 8, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | ($3.32M) | Apr 1, 2020 |
| FY2018 | Dec 31, 2017 | ($3.64M) | Apr 1, 2020 |
| FY2016 | Dec 31, 2016 | ($825.8K) | Apr 17, 2017 |
| FY2016 | Dec 31, 2015 | ($730.9K) | Apr 17, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $165.5K | Apr 9, 2026 |
| FY2025 | Dec 31, 2024 | $282.0K | Apr 9, 2026 |
| FY2024 | Dec 31, 2023 | ($415.7K) | Apr 22, 2025 |
| FY2023 | Dec 31, 2022 | ($390.6K) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($901.3K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($1.90M) | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | ($1.73M) | Aug 3, 2021 |
| FY2019 | Dec 31, 2018 | ($328.8K) | Aug 10, 2020 |
| FY2018 | Dec 31, 2017 | ($672.2K) | Apr 1, 2020 |
| FY2017 | Dec 31, 2016 | ($537.1K) | Jun 8, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $8.0K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Mar 31, 2023 |
| FY2020 | Dec 31, 2019 | $23.0K | Aug 3, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.82M | Apr 9, 2026 |
| FY2025 | Dec 31, 2024 | $2.38M | Apr 9, 2026 |
| FY2024 | Dec 31, 2023 | $2.64M | Apr 22, 2025 |
| FY2023 | Dec 31, 2022 | $2.78M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $3.03M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.12M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $3.45M | Aug 3, 2021 |
| FY2019 | Dec 31, 2018 | $85.8K | Aug 10, 2020 |
| FY2018 | Dec 31, 2017 | $1.12M | Apr 1, 2020 |
| FY2017 | Dec 31, 2016 | $146.2K | Jun 8, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.80M | Apr 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.97M | Apr 9, 2026 |
| FY2020 | Dec 31, 2020 | $261.6K | Aug 3, 2021 |
| FY2020 | Dec 31, 2019 | $4.32M | Aug 3, 2021 |
| FY2019 | Dec 31, 2018 | $3.65M | Aug 10, 2020 |
| FY2018 | Dec 31, 2017 | $2.30M | Apr 1, 2020 |
| FY2017 | Dec 31, 2016 | $2.51M | Jun 8, 2018 |
| FY2016 | Dec 31, 2015 | $25.2K | Apr 17, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.03M | Apr 9, 2026 |
| FY2025 | Dec 31, 2024 | $410.4K | Apr 9, 2026 |
| FY2025 | Dec 31, 2023 | $954.6K | Apr 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.87M | Apr 22, 2025 |
| FY2023 | Dec 31, 2021 | $2.47M | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | $2.85M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | ($865.6K) | Apr 1, 2022 |
| FY2020 | Dec 31, 2018 | ($3.56M) | Aug 3, 2021 |
| FY2019 | Dec 31, 2017 | ($1.18M) | Aug 10, 2020 |
| FY2018 | Dec 31, 2016 | ($2.36M) | Apr 1, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.12M | Apr 9, 2026 |
| FY2025 | Dec 31, 2024 | $193.3K | Apr 9, 2026 |
| FY2024 | Dec 31, 2023 | $193.3K | Apr 22, 2025 |
| FY2023 | Dec 31, 2022 | $193.3K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $193.3K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $193.3K | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $193.3K | Aug 3, 2021 |
| FY2018 | Dec 31, 2017 | $842.0K | Apr 1, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($20.12M) | Apr 9, 2026 |
| FY2025 | Dec 31, 2024 | ($19.24M) | Apr 9, 2026 |
| FY2024 | Dec 31, 2023 | ($18.40M) | Apr 22, 2025 |
| FY2023 | Dec 31, 2022 | ($15.93M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($14.94M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($12.96M) | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | ($10.38M) | Aug 3, 2021 |
| FY2019 | Dec 31, 2018 | ($11.01M) | Aug 10, 2020 |
| FY2018 | Dec 31, 2017 | ($7.68M) | Apr 1, 2020 |
| FY2017 | Dec 31, 2016 | ($4.12M) | Jun 8, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16.87M | Apr 9, 2026 |
| FY2025 | Dec 31, 2024 | 2.99M | Apr 9, 2026 |
| FY2024 | Dec 31, 2023 | 2.95M | Apr 22, 2025 |
| FY2023 | Dec 31, 2022 | 2.88M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 338.38M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 308.89M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | 121.61M | Aug 3, 2021 |
| FY2019 | Dec 31, 2018 | 3.03M | Aug 10, 2020 |
| FY2018 | Dec 31, 2017 | 898,422 | Apr 1, 2020 |
| FY2017 | Dec 31, 2016 | 17.16M | Jun 8, 2018 |